Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Standard BioTools Inc LAB

Technology Scientific & Technical Instruments
Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. The Company's segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments... see more

Recent & Breaking News (NDAQ:LAB)

Standard BioTools Appoints Alex Kim as Chief Financial Officer

GlobeNewswire November 7, 2024

Standard BioTools to Participate in Upcoming Investor Conferences

GlobeNewswire October 31, 2024

Standard BioTools Reports Third Quarter 2024 Financial Results

GlobeNewswire October 30, 2024

Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024

GlobeNewswire October 16, 2024

Standard BioTools Achieves New Record of the Most Protein Measurements on the Most Sample Types with Expansion of the SomaScan® 11K Platform

GlobeNewswire September 24, 2024

Standard BioTools proteomics profiling reveals unique biomarkers and insights into nonalcoholic steatohepatitis (NASH)

GlobeNewswire September 18, 2024

Standard BioTools to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

GlobeNewswire August 26, 2024

Standard BioTools to Participate in Upcoming Investor Conferences

GlobeNewswire August 6, 2024

Standard BioTools Announces Senior Leadership Changes

GlobeNewswire July 31, 2024

Standard BioTools Reports Second Quarter 2024 Financial Results

GlobeNewswire July 31, 2024

Standard BioTools Announces Conference Call and Webcast for Second Quarter 2024 Financial Results on July 31, 2024

GlobeNewswire July 17, 2024

Standard BioTools Purchases the Carterra® LSA-XT System to Accelerate Data Delivery and Provide Greater Validation to SomaScan Customers

GlobeNewswire May 28, 2024

Standard BioTools to Participate in Upcoming Investor Conferences

GlobeNewswire May 22, 2024

Standard BioTools Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire May 20, 2024

Standard BioTools Reports First Quarter 2024 Financial Results

GlobeNewswire May 8, 2024

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

GlobeNewswire April 25, 2024

Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024

GlobeNewswire April 25, 2024

Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging

GlobeNewswire April 8, 2024

Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research

GlobeNewswire April 3, 2024

Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock

GlobeNewswire March 18, 2024